Pomalidomide
An orally administered immunomodulatory antineoplastic drug used primarily in combination regimens for relapsed or refractory multiple myeloma and, in certain jurisdictions, for AIDS-related Kaposi sarcoma. Pomalidomide binds cereblon (CRBN), a substrate receptor of the CRL4 E3 ubiquitin ligase complex, promoting ubiquitination and proteasomal degradation of the transcription factors IKZF1 and IKZF3. This produces direct antimyeloma and immunomodulatory effects. Major risks include severe birth defects, myelosuppression, and venous thromboembolism
CAS Number: 19171-19-8
Molecular Mass: 273.24 g/mol
Formula: C13H11N3O4
Smiles: Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O
Bioactivity: Cereblon (CRBN)-binding immunomodulatory agent; molecular glue degrader of IKZF1 and IKZF3; antineoplastic and antiangiogenic agent
Solubility in Different Solvents
| Solvent | Temperature [K] | Crystal form | Solubility [mg/mL] | Reference |
|---|---|---|---|---|
| Acetone | 278.15 | - | 0.0054 | [136] |
| Acetone | 283.15 | - | 0.0075 | [136] |
| Acetone | 288.15 | - | 0.0097 | [136] |
| Acetone | 293.15 | - | 0.01234 | [136] |
| Acetone | 298.15 | - | 0.01577 | [136] |
| Acetone | 303.15 | - | 0.0195 | [136] |
| Acetone | 308.15 | - | 0.02376 | [136] |
| Acetone | 313.15 | - | 0.02831 | [136] |
| Acetone | 318.15 | - | 0.03399 | [136] |
| Ethanol | 278.15 | - | 9.0 × 10⁻⁴ | [136] |
| Ethanol | 283.15 | - | 0.00114 | [136] |
| Ethanol | 288.15 | - | 0.00146 | [136] |
| Ethanol | 293.15 | - | 0.00192 | [136] |
| Ethanol | 298.15 | - | 0.00247 | [136] |
| Ethanol | 303.15 | - | 0.0031 | [136] |
| Ethanol | 308.15 | - | 0.00391 | [136] |
| Ethanol | 313.15 | - | 0.0048 | [136] |
| Ethanol | 318.15 | - | 0.0057 | [136] |
| Ethyl acetate | 278.15 | - | 0.00128 | [136] |
| Ethyl acetate | 283.15 | - | 0.00187 | [136] |
| Ethyl acetate | 288.15 | - | 0.00261 | [136] |
| Ethyl acetate | 293.15 | - | 0.0034 | [136] |
| Ethyl acetate | 298.15 | - | 0.0043 | [136] |
| Ethyl acetate | 303.15 | - | 0.0054 | [136] |
| Ethyl acetate | 308.15 | - | 0.0065 | [136] |
| Ethyl acetate | 313.15 | - | 0.00804 | [136] |
| Ethyl acetate | 318.15 | - | 0.0098 | [136] |
| Isopropanol | 278.15 | - | 8.0 × 10⁻⁴ | [136] |
| Isopropanol | 283.15 | - | 0.0012 | [136] |
| Isopropanol | 288.15 | - | 0.00172 | [136] |
| Isopropanol | 293.15 | - | 0.00225 | [136] |
| Isopropanol | 298.15 | - | 0.00288 | [136] |
| Isopropanol | 303.15 | - | 0.0036 | [136] |
| Isopropanol | 308.15 | - | 0.0044 | [136] |
| Isopropanol | 313.15 | - | 0.0054 | [136] |
| Isopropanol | 318.15 | - | 0.0066 | [136] |
Molecule 3D descriptors
| Descriptor | Value |
|---|---|
| PMI1 | 565.4070 |
| PMI2 | 2563.2448 |
| PMI3 | 2788.9041 |
| NPR1 | 0.2027 |
| NPR2 | 0.9191 |
| RadiusOfGyration | 3.2906 |
| InertialShapeFactor | 0.0016 |
| Eccentricity | 0.9792 |
| Asphericity | 0.5132 |
| SpherocityIndex | 0.2012 |
| PBF | 0.6029 |